ScholarIQanswers from OpenAlex & ORCID
Vittorio Gebbia
ResearcherPublications, citations & collaboration network
Vittorio Gebbia is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Vittorio Gebbia have?
ScholarIQindexed works
Vittorio Gebbia has 458 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Vittorio Gebbia have?
ScholarIQcitation count
Vittorio Gebbia has 17,262 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Vittorio Gebbia?
ScholarIQh-index
Vittorio Gebbia has an h-index of 53 in OpenAlex.
What is the i10-index of Vittorio Gebbia?
ScholarIQi10-index
Vittorio Gebbia has an i10-index of 185 in OpenAlex.
What is the ORCID of Vittorio Gebbia?
ScholarIQorcid
The ORCID for Vittorio Gebbia is on the source record.
What is the OpenAlex record for Vittorio Gebbia?
ScholarIQopenalex
The OpenAlex for Vittorio Gebbia is on the source record.
What are the most-cited papers on Vittorio Gebbia?
ScholarIQmost cited works
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rafael Rosell, Enric Carcereny, Radj Gervais, A. Vergnenègre, Bartomeu Massutí, Enriqueta Felip, Ramón Palmero, Ramón García-Gómez, Cinta Pallarés, José Miguel Sánchez, Rut Porta, Manuel Cobo, Pilar Garrido, Flavia Longo, Teresa Morán, Amelia Insa, Filippo de Marinis, R. Corre, Isabel Bover, Alfonso Illiano, Éric Dansin, Javier de Castro, Michèle Milella, Noemı́ Reguart, Giuseppe Altavilla, Ulpiano Jiménez, Mariano Provencio, Miguel Ángel Moreno, Josefa Terrasa, José Muñoz-Langa, Javier Valdivia, Dolores Isla, Manuel Dómine, Olivier Molinier, Julien Mazières, Nathalie Baize, Rosario García‐Campelo, G. Robinet, Delvys Rodríguez‐Abreu, Guillermo López-Vivanco, Vittorio Gebbia, Lioba Ferrera-Delgado, P. Bombaron, Reyes Bernabé, Alessandra Bearz, Á. Artal, Enrico Cortesi, Christian Rolfo, María Sanchez-Ronco, Ana Drozdowskyj, Cristina Queralt, Itziar de Aguirre, José Luis Ramírez, José Javier Sánchez, Miguel Ángel Molina‐Vila, Miquel Tarón, Luis Paz‐Ares
Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial
C. Gridelli, Federica Perrone, Ciro Gallo, S. Cigolari, Antônio Rossi, Franco Vito Piantedosi, Santi Barbera, Francesco Ferraù, E. Piazza, Francesco Rosetti, M. Clerici, Oscar Bertetto, Sergio Robbiati, L. Frontini, Chiara Sacco, Fabiana Castiglione, Adolfo Favaretto, Silvia Novello, M.R. Migliorino, Giampietro Gasparini, Domenico Galetta, R. V. Iaffaioli, Vittorio Gebbia
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
Cesare Gridelli, Fortunato Ciardiello, Ciro Gallo, Ronald Feld, Charles Butts, Vittorio Gebbia, Paolo Maione, Floriana Morgillo, Giovenzio Genestreti, Adolfo Favaretto, Natasha B. Leighl, Rafal Wierzbicki, Saverio Cinieri, Yasmin Alam, Salvatore Siena, Giampaolo Tortora, Raffaella Felletti, Ferdinando Riccardi, Gianfranco Mancuso, Antônio Rossi, Flavia Cantile, Ming‐Sound Tsao, Mauro Saieg, Gilda da Cunha Santos, Maria Carmela Piccirillo, Massimo Di Maïo, Alessandro Morabito, Francesco Perrone